Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jing Su Ke Li versus placebo for cervical spondylotic radiculopathy
ChiCTR1900021012Phase 4Completed
- Sponsor
- Chinese Academy of Medical Sciences and Peking Union Medical College
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of jingshu granules in cervical spondylotic radiculopathy (CSR) (2 arms), sponsored by Chinese Academy of Medical Sciences and Peking Union Medical College. Primary endpoint: Change in pain VAS score from baseline. Started Feb 2018; status: completed.
02
Drugs
jingshu granules
03
Conditions
cervical spondylotic radiculopathy (CSR)
Beyond the preview
Go deeper on ChiCTR1900021012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021012.